VGF and prostate carcinoma: We experimentally validated the novel radioresistance marker gene candidate VGF, a neuroendocrine factor, that was highly overexpressed in DU145 and LNCaP radioresistant prostate cancer cell lines and whose high expression was associated with shorter disease-free survival of irradiated prostate cancer patients.